Answers are grounded in this paper and cite their sources.
Targeting subcellular organelles, particularly the nucleus, has emerged as a compelling paradigm to amplify the efficacy of photodynamic (PDT) and photothermal therapies (PTT), as nuclear-localized photosensitizers can directly inflict irreparable DNA damage and disrupt nuclear membrane integrity, thereby triggering profound apoptotic pathways. However, achieving efficient nuclear delivery of clinically approved near-infrared dyes such as indocyanine green (ICG) remains challenging due to stringent size exclusion constraints of the nuclear pore complex and the lack of intrinsic nuclear tropism. To address this bottleneck, we herein engineer a nucleus-targeted nanoplatform (SPIO-SiO2-PEG-NLS@ICG) based on ultrasmall superparamagnetic iron oxide (SPIO) cores. Critically, the sub-10 nm diameter of the SPIO core is deliberately selected to meet the physical size prerequisites for active nuclear translocation, while surface-functionalized nuclear localization signal (NLS) peptides provide the biological driving force for directional trafficking into the nucleus. Both in vitro and in vivo evaluations confirmed that these nanoparticles significantly enhanced ICG accumulation within breast tumors in mice and facilitated laser-triggered nuclear delivery. This confined intranuclear localization led to amplified ROS production and highly localized hyperthermia within tumor cells. Furthermore, the ICG-loaded SPIO nanoparticles exhibited favorable performance in both fluorescence imaging and T2-weighted magnetic resonance imaging (MRI). Collectively, the nucleus-targeted SPIO-SiO2-PEG-NLS@ICG nanoplatform synergistically integrates potent PDT/PTT activity with high-fidelity multimodal imaging, thereby significantly improving antitumor therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: